Tuesday, 19 August 2003: 15:45-17:15
Ontario Room (Sheraton Hotel and Towers)

S048 Mild Cognitive Impairment: Identification, Progression, and Treatment

 S048-001 Variations in Case Definition Affect Prevalence but Not Outcomes of Mild Cognitive Impairment
John D Fisk, Kenneth Rockwood, Heather Merry
 S048-002 Assessing Progression from MCI to Dementia Using the Cambridge Cognitive Examination (CAMCOG)
Mirco Neri, Emilio Martini, Francesca Neviani, Carlo Cipolli, Erika Suzzi
 S048-003 Donepezil-Treated Alzheimer’s Disease Patients with Apparent Initial Cognitive Decline Demonstrate Significant Benefits When Therapy is Continued: Results From a Randomized, Placebo-Controlled Trial
P Johannsen, M Barcikowska, P Dautzenberg, H Hampel, S Hasselbalch, P Sakka, E Salmon, H Tilker, F Túry, S Qvitzau, S Richardson, Y Xu, E Schwam, R Schindler
 S048-004 Donepezil Treatment Provides Benefits in Patients With Mild Cognitive Impairment
Stephen P Salloway, Robert Goldman, Dinesh Kumar, J Ieni, Teresa Griesing, Sharon Richardson
 S048-005 Behavioral and Cognitive Deficits in MCI-Patients
Louisa H. Fischer-Altevogt, Pasquale Calabrese
 S048-006 Proton NMR Spectroscopy in Mild Cognitive Impairment: Early Right Hippocampal Involvement
Maria T Caserta, Ann Ragin, R. John Ahrens

Back to The Eleventh International Congress